A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern

CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization (WHO). Previous studies reported increased levels of neutralizing antibodies and specific T cells 2 and 4 weeks after two doses of CoronaVac; these levels were significantly reduced at 6 to 8 months after the tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Bárbara M., Melo-González, Felipe, Duarte, Luisa F., Gálvez, Nicolás M. S., Pacheco, Gaspar A., Soto, Jorge A., Berríos-Rojas, Roslye V., González, Liliana A., Moreno-Tapia, Daniela, Rivera-Pérez, Daniela, Ríos, Mariana, Vázquez, Yaneisi, Hoppe-Elsholz, Guillermo, Andrade-Parra, Catalina A., Vallejos, Omar P., Piña-Iturbe, Alejandro, Iturriaga, Carolina, Urzua, Marcela, Navarrete, María S., Rojas, Álvaro, Fasce, Rodrigo, Fernández, Jorge, Mora, Judith, Ramírez, Eugenio, Gaete-Argel, Aracelly, Acevedo, Mónica L., Valiente-Echeverría, Fernando, Soto-Rifo, Ricardo, Weiskopf, Daniela, Grifoni, Alba, Sette, Alessandro, Zeng, Gang, Meng, Weining, González-Aramundiz, José V., González, Pablo A., Abarca, Katia, Kalergis, Alexis M., Bueno, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426482/
https://www.ncbi.nlm.nih.gov/pubmed/35946814
http://dx.doi.org/10.1128/mbio.01423-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426482/
https://www.ncbi.nlm.nih.gov/pubmed/35946814
http://dx.doi.org/10.1128/mbio.01423-22

Ejemplares similares